Davos Agenda

This is why the private sector should support equitable vaccine R&D and manufacturing

The Open Society and others support companies committed to taking the risks involved in creating more distributed COVID vaccine production.

Supporting a private sector committed to more distributed vaccine production. Image:  Tima Miroshnichenko from Pexels

Lord Mark Malloch-Brown
President, Open Society Foundations
Share:
Our Impact
The Big Picture
Explore and monitor how Private Investors is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Davos Agenda

Have you read?
Image: Our World in Data
Discover

What is the World Economic Forum doing about fighting pandemics?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Davos AgendaPrivate InvestorsGlobal Health
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

More on Davos Agenda
See all

Electric car sales have surged in Europe - so why is adoption still slow?

Andrea Willige

November 13, 2023

4:21

Annual Meeting 2023 | Cooperation in a Fragmented World

About Us

Events

Media

More from the Forum

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum